DEPDC1 and plasma cell myeloma: In addition, several studies have found that longer survival in patients with multiple myeloma and hepatocellular carcinoma was significantly correlated with a lower DEPDC1 expression, suggesting that DEPDC1 may be a new diagnostic marker (30, 31).